CASE REPORT
|
doi:10.20944/preprints202406.1349.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Daratumumab, multiple myeloma, treatment, maintenance
Online: 19 June 2024 (11:55:41 CEST)
ARTICLE
|
doi:10.20944/preprints202405.1516.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Natural killer cells; daratumumab; multiple myeloma; KIR-NKP46+
Online: 23 May 2024 (12:34:34 CEST)
REVIEW
|
doi:10.20944/preprints202309.1180.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
myeloma; daratumumab; bispecific antibodies; chimeric antigen receptor T-cells; immunotherapy
Online: 19 September 2023 (05:28:58 CEST)
CASE REPORT
|
doi:10.20944/preprints202209.0161.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
Antibody-mediated rejection; Crossmatch; Daratumumab; End-stage renal disease; Flow cytometry; HLA; Multiple myeloma; Transplantation
Online: 13 September 2022 (05:48:27 CEST)
ARTICLE
|
doi:10.20944/preprints202109.0300.v1
Subject:
Computer Science And Mathematics,
Applied Mathematics
Keywords:
CAR T; Targeted Radionuclide Therapy; TRT; Mathematical Model; Multiple Myeloma; Immunotherapy; Daratumumab; CS1; Combination Therapy
Online: 17 September 2021 (09:32:33 CEST)
REVIEW
|
doi:10.20944/preprints201810.0577.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
myeloma; daratumumab; elotuzumab; isatuximab; CD38; JNJ- 63723283; denosumab; checkpoint inhibitors; BCMA; bispecific T-cell engager; antibody-drug conjugates
Online: 24 October 2018 (12:11:23 CEST)